Suppr超能文献

脑大麻素受体2:表达、功能及调节

Brain cannabinoid receptor 2: expression, function and modulation.

作者信息

Chen De-Jie, Gao Ming, Gao Fen-Fei, Su Quan-Xi, Wu Jie

机构信息

Department of Neurology, Yunfu People's Hospital, Yunfu 527300, China.

Department of Neurobiology, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, AZ 85013-4409, USA.

出版信息

Acta Pharmacol Sin. 2017 Mar;38(3):312-316. doi: 10.1038/aps.2016.149. Epub 2017 Jan 9.

Abstract

Cannabis sativa (marijuana) is a fibrous flowering plant that produces an abundant variety of molecules, some with psychoactive effects. At least 4% of the world's adult population uses cannabis annually, making it one of the most frequently used illicit drugs in the world. The psychoactive effects of cannabis are mediated primarily through cannabinoid receptor (CBR) subtypes. The prevailing view is that CB1Rs are mainly expressed in the central neurons, whereas CBRs are predominantly expressed in peripheral immune cells. However, this traditional view has been challenged by emerging strong evidence that shows CBRs are moderately expressed and function in specific brain areas. New evidence has demonstrated that brain CBRs modulate animal drug-seeking behaviors, suggesting that these receptors may exist in brain regions that regulate drug addiction. Recently, we further confirmed that functional CBRs are expressed in mouse ventral tegmental area (VTA) dopamine (DA) neurons and that the activation of VTA CBRs reduces neuronal excitability and cocaine-seeking behavior. In addition, CBR-mediated modulation of hippocampal CA3 neuronal excitability and network synchronization has been reported. Here, we briefly summarize recent lines of evidence showing how CBRs modulate function and pathophysiology in the CNS.

摘要

大麻( Cannabis sativa )是一种纤维状开花植物,能产生多种分子,其中一些具有精神活性作用。全球至少4%的成年人口每年使用大麻,使其成为世界上最常用的非法药物之一。大麻的精神活性作用主要通过大麻素受体(CBR)亚型介导。普遍观点认为,CB1Rs主要在中枢神经元中表达,而CBRs主要在外周免疫细胞中表达。然而,这一传统观点受到了新出现的有力证据的挑战,这些证据表明CBRs在特定脑区有中度表达并发挥功能。新证据表明,脑内CBRs调节动物的觅药行为,提示这些受体可能存在于调节药物成瘾的脑区。最近,我们进一步证实功能性CBRs在小鼠腹侧被盖区(VTA)多巴胺(DA)神经元中表达,并且VTA CBRs的激活降低神经元兴奋性和可卡因觅求行为。此外,已有报道称CBR介导对海马CA3神经元兴奋性和网络同步性的调节。在此,我们简要总结最近一系列证据,展示CBRs如何调节中枢神经系统的功能和病理生理。

相似文献

1
Brain cannabinoid receptor 2: expression, function and modulation.
Acta Pharmacol Sin. 2017 Mar;38(3):312-316. doi: 10.1038/aps.2016.149. Epub 2017 Jan 9.
2
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):E5007-15. doi: 10.1073/pnas.1413210111. Epub 2014 Nov 3.
3
Mechanisms of cannabinoid CB receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area.
EBioMedicine. 2019 Apr;42:225-237. doi: 10.1016/j.ebiom.2019.03.040. Epub 2019 Apr 3.
4
The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders.
Acta Pharmacol Sin. 2020 Dec;41(12):1507-1518. doi: 10.1038/s41401-020-00530-2. Epub 2020 Oct 6.
5
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.
Neuroscience. 2015 Dec 17;311:253-67. doi: 10.1016/j.neuroscience.2015.10.041. Epub 2015 Oct 26.
6
Progress in brain cannabinoid CB receptor research: From genes to behavior.
Neurosci Biobehav Rev. 2019 Mar;98:208-220. doi: 10.1016/j.neubiorev.2018.12.026. Epub 2019 Jan 3.
7
Cannabinoid CB receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice.
Neuropharmacology. 2021 May 15;189:108538. doi: 10.1016/j.neuropharm.2021.108538. Epub 2021 Mar 28.
8
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus.
Neuroscience. 2017 Nov 5;363:11-25. doi: 10.1016/j.neuroscience.2017.08.053. Epub 2017 Sep 6.
9
Hippocampal Cb receptors: an untold story.
Rev Neurosci. 2021 Oct 29;33(4):413-426. doi: 10.1515/revneuro-2021-0109. Print 2022 Jun 27.
10
Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Ann N Y Acad Sci. 2006 Aug;1074:514-36. doi: 10.1196/annals.1369.052.

引用本文的文献

1
Development of Carborane-Based Benzothiazole Analogues as Cannabinoid Receptor Type 2 (CBR) Ligands.
ACS Omega. 2025 Aug 13;10(33):38264-38271. doi: 10.1021/acsomega.5c06508. eCollection 2025 Aug 26.
3
Synthesis and Pharmacological Characterization of a Novel Cannabinoid Receptor 1 Antagonist.
ACS Omega. 2025 Jun 2;10(22):22747-22759. doi: 10.1021/acsomega.4c11355. eCollection 2025 Jun 10.
4
Coadministration antagonist dopamine receptor D4 with CB2 receptor agonist decreases binge-like intake of palatable food in mice.
Front Behav Neurosci. 2025 Apr 29;19:1572374. doi: 10.3389/fnbeh.2025.1572374. eCollection 2025.
5
Cannabinoids in Chronic Pain Management: A Review of the History, Efficacy, Applications, and Risks.
Biomedicines. 2025 Feb 20;13(3):530. doi: 10.3390/biomedicines13030530.
7
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effects.
Nat Commun. 2025 Mar 6;16(1):2237. doi: 10.1038/s41467-025-57136-7.
10
Therapeutic potential of agents targeting cannabinoid type 2 receptors in organ fibrosis.
Pharmacol Res Perspect. 2024 Dec;12(6):e1219. doi: 10.1002/prp2.1219.

本文引用的文献

2
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease.
Exp Neurol. 2016 Sep;283(Pt A):204-12. doi: 10.1016/j.expneurol.2016.06.014. Epub 2016 Jun 15.
3
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease.
Front Neurosci. 2016 May 31;10:243. doi: 10.3389/fnins.2016.00243. eCollection 2016.
4
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.
Neuron. 2016 May 18;90(4):795-809. doi: 10.1016/j.neuron.2016.03.034. Epub 2016 Apr 28.
5
Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons.
Pflugers Arch. 2016 Apr;468(4):727-37. doi: 10.1007/s00424-015-1782-5. Epub 2016 Jan 7.
6
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.
Neuroscience. 2015 Dec 17;311:253-67. doi: 10.1016/j.neuroscience.2015.10.041. Epub 2015 Oct 26.
7
Time-Dependent Protection of CB2 Receptor Agonist in Stroke.
PLoS One. 2015 Jul 17;10(7):e0132487. doi: 10.1371/journal.pone.0132487. eCollection 2015.
9
Differential upregulation of the cannabinoid CB₂ receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease.
Exp Neurol. 2015 Jul;269:133-41. doi: 10.1016/j.expneurol.2015.04.007. Epub 2015 Apr 18.
10
Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:200-8. doi: 10.1016/j.pnpbp.2015.03.017. Epub 2015 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验